New knowledge in application of vaccines with Kina(K)strain in control and curbing of classical swine fever

The program of curbing and outrooting classical swine fever (CSF) in our country has for years been based on the vaccination of all categories of swine with the Kina (K) strain of the CSF virus, and, after the establishment of the source of infection, with the non-harmful removal of the infected swi...

Full description

Bibliographic Details
Main Authors: Prodanov Jasna, Došen Radoslav, Polaček Vladimir, Petrović Tamaš, Lupulović Diana
Format: Article
Language:srp
Published: Faculty of Veterinary Medicine, Belgrade 2006-01-01
Series:Veterinarski Glasnik
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0350-2457/2006/0350-24570604241P.pdf
Description
Summary:The program of curbing and outrooting classical swine fever (CSF) in our country has for years been based on the vaccination of all categories of swine with the Kina (K) strain of the CSF virus, and, after the establishment of the source of infection, with the non-harmful removal of the infected swine herd, as well as on the implementation of all measures prescribed by the valid regulations. However, in spite of the implementation of all the listed measures, CSF still occurs continually. The epizootiological situation in our country in the course of 2005 was extremely unfavorable from the aspect of the number of identified CSF crisis spots, and it can be pointed out at this time that the disease was diagnosed clinically, pathomorphologically and using laboratory methods in 51 farms in a single examined epizootiological district. Under conditions when CSF appears continually throughout the year, vaccination using a modified live vaccine must continue being the basic measure in preventing the appearance, spreading, curbing, and eradication of CSF. With the objective of securing a concept of the most efficient further strategy for control and curbing of this disease, the paper presents the most important aspects regarding efficacy, safety, as well as field experience in applying vaccines which are based on the K strain of the CSF virus. .
ISSN:0350-2457
2406-0771